Heart failure in dystrophin-deficient (mdx) mice : role of stretch-activated channels and reactive oxygen species
| Field | Value | Language |
| dc.contributor.author | Williams, Iwan Alban | |
| dc.date.accessioned | 2023-11-22T01:09:09Z | |
| dc.date.available | 2023-11-22T01:09:09Z | |
| dc.date.issued | 2007 | en |
| dc.identifier.uri | https://hdl.handle.net/2123/31899 | |
| dc.description.abstract | Duchenne muscular dystrophy (DMD) is caused by deficiency of the cytoskeletal protein dystrophin. DMD patients develop a dilated cardiomyopathy. The first half of this thesis explores the possibility that dystrophin is involved in the regulation of a stretch-activated channel (SAC). Because cardiac failure only appears late in the progression of DMD. we examined age—related effects in the mdx mouse, an animal model of DMD. Old mdx (9-12 months) mice had raised resting intracellular Ca2+ concentration ([Ca2+]i), while cardiomyocytes from young (9 weeks) and old mdx mice displayed abnormal Ca2+ transients and Ca2+ handling protein expression. Old mdx mice had increased protein expression of TRPCl, a likely candidate protein for SACs, while the SAC inhibitors streptomycin and GsMTx-4 reduced resting [Ca2+], in old mdx mice. These observations suggest that SACs may be involved in the Ca2+ handling abnormalities in these animals. Thus, SACs may play a role in the pathogenesis of the heart failure associated with DMD. The second half of this thesis investigated the effects of the antioxidant N-acetylcysteine (NAC) on myocardial function in young (9 weeks) mdx mice following 6 weeks of treatment. NAC had no effect on wild type mice. Experiments revealed that mdx mice had increased reactive oxygen species levels; NAC-treatment reduced ROS levels in mdx hearts. NACtreatment attenuated abnormalities in mdx cardiomyocyte Ca2+ handling, reversed defects in mdx myofilament function, and prevented myocardial inflammation. de hearts had increased NADPH oxidase activity, a ROS producing enzyme, suggesting it could be a possible source of augmented ROS in mdx mice. Therapies designed to reduce oxidative damage might be beneficial to DMD patients with heart failure. | en |
| dc.language.iso | en | en |
| dc.rights | Copyright All Rights Reserved | en |
| dc.subject | Dystrophin | en |
| dc.subject | Duchenne muscular dystrophy | en |
| dc.subject | Genetic aspects | en |
| dc.subject | Heart failure | en |
| dc.subject | Pathophysiology | en |
| dc.subject | Myocardium | en |
| dc.subject | Diseases | en |
| dc.subject | Active oxygen | en |
| dc.subject | Physiological effect | en |
| dc.subject | Mice | en |
| dc.subject | Muscles | en |
| dc.title | Heart failure in dystrophin-deficient (mdx) mice : role of stretch-activated channels and reactive oxygen species | en |
| dc.type | Thesis | |
| dc.type.thesis | Doctor of Philosophy | en |
| dc.rights.other | The author retains copyright of this thesis. It may only be used for the purposes of research and study. It must not be used for any other purposes and may not be transmitted or shared with others without prior permission. | en |
| usyd.faculty | SeS faculties schools::Faculty of Medicine and Health::School of Health Sciences | en |
| usyd.degree | Doctor of Philosophy Ph.D. | en |
| usyd.awardinginst | The University of Sydney | en |
Associated file/s
Associated collections